tiprankstipranks
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Income Statement

Compare
2 Followers

NATCO Pharma Limited Income Statement

Last quarter (Q4 2023), NATCO Pharma Limited's total revenue was ₹13.63B, an increase of 19.47% from the same quarter last year. In Q4, NATCO Pharma Limited's net income was ₹6.68B. See NATCO Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 40.02B₹ 27.07B₹ 19.05B₹ 16.90B₹ 18.88B
Gross Profit
₹ 31.39B₹ 20.80B₹ 12.23B₹ 10.82B₹ 13.78B
Operating Expenses
₹ 31.16B₹ 13.08B₹ 10.81B₹ 5.81B₹ 8.87B
Depreciation and Amortization
₹ 1.87B₹ 1.64B₹ 1.43B₹ 1.17B₹ 998.00M
EBITDA
₹ 18.80B₹ 10.40B₹ 3.63B₹ 7.10B₹ 6.90B
Operating Income
₹ 25.96B₹ 8.76B₹ 2.20B₹ 5.01B₹ 4.91B
Other Income/Expenses
₹ -9.23B₹ -6.30B₹ -4.91B₹ -3.52B₹ 775.00M
Pretax Income
₹ 16.73B₹ 8.62B₹ 2.02B₹ 5.80B₹ 5.69B
Net Income
₹ 13.88B₹ 7.15B₹ 1.70B₹ 4.41B₹ 4.61B
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 77.34₹ 39.18₹ 9.32₹ 24.20₹ 25.33
Diluted EPS
₹ 77.34₹ 39.18₹ 9.32₹ 24.16₹ 25.26
Weighted Average Shares Outstanding
179.51M 182.55M 182.37M 182.16M 181.93M
Weighted Average Shares Outstanding (Diluted)
179.50M 182.55M 182.41M 182.49M 182.46M
Currency in INR

NATCO Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis